Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate for Non-invasive Lentigo Melanoma of the Face
NCT02723721Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Jun 2016
- Primary completion
- Jan 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol mebutate in lentigo maligna (LM), sponsored by Centre Hospitalier Universitaire de Nice. Started Jun 2016; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
lentigo maligna (LM)
Beyond the preview
Go deeper on NCT02723721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723721.